AstraZeneca teams up with Torrent in Generics

12 Mar 2010 Evaluate

AstraZeneca Plc signed an agreement with Torrent Pharmaceuticals Ltd. to brand and market 18 of the Indian drug maker medicines in 9 emerging economies, marking the U.K. drug maker’s first generic-drug partnership. Under the terms of the alliance, AstraZeneca may purchase additional product licenses and enter new markets with Torrent.

 

AstraZeneca is expanding in so-called branded generics as it seeks to boost sales in emerging markets to 25 percent of annual revenue by 2014, from 13 percent in 2009. Branded generics is a way to accelerate growth in emerging markets.

 

AstraZeneca follows U.K. peer GlaxoSmithKline Plc and Sanofi-Aventis SA of France in its foray into the growing market for lower-priced copied medicines as drug makers seek generic- drug acquisitions and product deals to cushion the loss of sales from medicines that have lost patent protection.

crackcrack

Astrazeneca Pharma I Share Price

5500.00 55.45 (1.02%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.